Authors' response

Wiley V. Chan, Physician, Internal Medicine; Director, Guidelines & Evidence-Based Medicine,

Other Contributors:

August 08, 2006

Dear Editor,

Our sincere apologies. We realized that we mistakenly stated that the Wilson version of the Framingham risk predictor has a variable for antihypertensive treatment. In fact, this variable does not appear in the Wilson version, but it does in appear in subsequent Framingham risk predictors. Please accept this corrected letter.

Conflict of Interest

None declared